Pharmaceuticals 2010, 3(3), 482-513; doi:10.3390/ph3030482
Review

The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis

Department of Human Anatomy and Histology, University of Bari Medical School, Piazza G. Cesare, 11, Policlinico 70124, Bari, Italy
Received: 12 January 2010; in revised form: 29 January 2010 / Accepted: 2 March 2010 / Published: 8 March 2010
(This article belongs to the Special Issue Angiogenesis Inhibitors)
PDF Full-text Download PDF Full-Text [219 KB, uploaded 8 March 2010 08:52 CET]
Abstract: Antiangiogenesis, e.g., inhibition of blood vessel growth, is being investigated as a way to prevent the growth of tumors and other angiogenesis-dependent diseases. Pharmacological inhibition interferes with the angiogenic cascade or the immature neovasculature with synthetic or semi-synthetic substances, endogenous inhibitors or biological antagonists.The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane, which serves as a gas exchange surface and its function is supported by a dense capillary network. Because its extensive vascularization and easy accessibility, CAM has been used to study morphofunctional aspects of the angiogenesis process in vivo and to study the efficacy and mechanism of action of pro- and anti-angiogenic molecules. The fields of application of CAM in the study of antiangiogenesis, including our personal experience, are illustrated in this review article.
Keywords: antiangiogenesis; chorioallantoic membrane; tumor progression

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Ribatti, D. The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis. Pharmaceuticals 2010, 3, 482-513.

AMA Style

Ribatti D. The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis. Pharmaceuticals. 2010; 3(3):482-513.

Chicago/Turabian Style

Ribatti, Domenico. 2010. "The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis." Pharmaceuticals 3, no. 3: 482-513.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert